Dachaigh › Luchd-obrach › Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Obsidian Therapeutics, Inc. 11 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 11. Tuarastal meadhanach a chaidh a thabhann: $109,710.
A bheil Obsidian Therapeutics, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Obsidian Therapeutics, Inc. 11 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 12 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior QA Operations Manager | 2 | $139,886 |
| Associate Scientist, Cell Therapy | 2 | $106,706 |
| Quality Assurance Manager | 1 | $120,175 |
| Senior Research Associate | 1 | $87,485 |
| Senior Research Associate, Cell Therapy | 1 | $88,825 |
| Research Associate, Analytical Development | 1 | $82,000 |
| Program Management Associate | 1 | $109,710 |
| Associate Scientist, Analytical Development | 1 | $110,000 |
| Scientist, Viral Vector Analytical Development | 1 | $135,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $88,825 |
| FY2025 | 3 | $109,710 |
| FY2026 | 5 | $110,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Molecular and Cellular Biologists6
- Regulatory Affairs Specialists2
- Medical Scientists, Except Epidemiologists2
- Regulatory Affairs Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior QA Operations Manager | $142,292 Ìre IV | Downington, PA | 12 Ògmh 2026 | 12 Dùbh 2026 | Dearbhaichte |
| Associate Scientist, Cell Therapy | $106,708 Ìre II | Cambridge, MA | 1 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Associate Scientist, Cell Therapy | $106,704 Ìre II | Cambridge, MA | 1 Cèit 2026 | 16 Ògmh 2026 | Dearbhaichte |
| Scientist, Viral Vector Analytical Development | $135,000 Ìre IV | Bedford, MA | 17 Gibl 2026 | 18 Cèit 2026 | Dearbhaichte |
| Associate Scientist, Analytical Development | $110,000 Ìre II | Bedford, MA | 5 Dùbh 2025 | 5 Faoi 2026 | Dearbhaichte |
| Program Management Associate | $109,710 Ìre II | Bedford, MA | 22 Lùna 2025 | 25 Lùna 2025 | Dearbhaichte |
| Research Associate, Analytical Development | $82,000 Ìre I | Bedford, MA | 14 Cèit 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Senior QA Operations Manager | $137,480 Ìre IV | Downington, PA | 2 Gibl 2025 | 2 Gibl 2025 | Dearbhaichte |
| Senior Research Associate | $87,485 Ìre II | Cambridge, MA | 2 Cèit 2023 | 16 Ògmh 2023 | Dearbhaichte |
| Senior Research Associate, Cell Therapy | $88,825 Ìre II | Cambridge, MA | 31 Màrt 2023 | 30 Sult 2023 | Dearbhaichte |
| Quality Assurance Manager | $120,175 Ìre II | Malvern, PA | 22 Gearr 2023 | 1 Gibl 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).